Labiotech.eu

crispr therapeutics muscle stem cells anagenesis

News and Trends 10 Jun 2016

CRISPR Thx in yet another Collaboration, this time for Muscle Dystrophy

CRISPR Therapeutics has struck a deal with Anagenesis Biotechnologies, which has key technology for muscle stem cells. Together, they will tackle muscle disorders – including the rare disease Duchenne Muscular Dystrophy (DMD). CRISPR Therapeutics (Basel, Switzerland) is the European champion of gene editing for health applications, a field that promises to revolutionize therapies – even if […]

June 10, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 10 Jun 2016

Genticel is vaccinating against Cervical Cancer AFTER Infection

Estonia, our previous destination by the Baltic Sea, was a delightful and a full of potential place to visit. This week, we are heading down to the relaxing and sunny south of France, more precisely to Toulouse, once the capital of the Visigothic Kingdom and current to the Midi-Pyrénées region, the largest region in metropolitan France. It […]

June 10, 2016 - 2 minutesmins - By Joachim Eeckhout

asco biotech morphosys cancer chicago 2016 researh pharma

News and Trends 9 Jun 2016

How was it inside the ‘World Most Important Cancer Meeting’ of the Year?

Every year by the end of May/beginning of June, up to 30,000 of healthcare professionals head to Chicago to discuss the most recent advancements in Cancer treatments. Here, the MorphoSys team, which included Claudia Gutjahr-Löser and Jochen Orlowski, give you a sneak-insiders look into one of the most essential Cancer conferences of the year… You can also […]

June 9, 2016 - 4 minutesmins - By Dani Bancroft

News and Trends 9 Jun 2016

German Biotech launches Phase II in a hot Target for Inflammation

InflaRx has treated the first patient in a new Phase II trial, which is studying the potential of its anti-complement antibody in avoiding immunological complications after complex cardiac surgery – a big unmet need. It is competing with world most expensive drug Soliris from Alexion (US). Based in Jena (Germany), InflaRx specializes in developing new […]

June 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

huntingtons rochester copenhagen glia transplant

News and Trends 9 Jun 2016

Brain Cell Transplant could help with incurable Neurodegenerative Disease

Researchers from Copenhagen and the US have succeeded in slowing the progression of Huntington’s disease in mice with a transplant of healthy human brain cells. This provides a new route to tackle this incurable fatal disease. Cell therapies are promising for some of the most serious diseases, from their role in cancer treatment (one of the […]

June 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

global bioenergies l oreal loreal cristal union isobutene cosmetic biofuel biotech

News and Trends 9 Jun 2016

Biotech, France and L’Oréal Team up for World First Biofuel Plant using Beets

The Investissements d’Avenir programme (a French government initiative) is providing €9M to both Global Bioenergies and IBN-One, as part of an project involving Cristal Union (the agro-business for Beet production) and L’Oréal (the cosmetics Giant). Together, they will develop the first commercial plant producing bio-sourced isobutene worldwide. Broken down into €5.7M for Global Bioenergies; €3.3M for IBN-One, the […]

June 9, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 8 Jun 2016

12 European Biotechs which ‘stole the show’ at World most Important Cancer Meeting

Pharma and Biotech from every corner flocked to Chicago for the beginning of June. Why? It’s where one of the biggest oncology events happens – the ASCO Annual Meeting 2016. Shortly after the AACR annual meeting (with presentations from several European Biotechs), it’s time for the ASCO annual meeting. Hosted by the American Society of Clinical […]

June 8, 2016 - 7 minutesmins - By Denise Neves Gameiro

News and Trends 7 Jun 2016

New Massive €250M Investment Fund Closed for European Biotech

Life Sciences Partners (LSP) has closed its new life sciences fund, ‘LSP5’. The fund surpassed its €152M target and reached the ‘hard cap’ of €250M, making it one of the largest life sciences funds in the EU. LSP is one of the oldest and most successful Biotech investors in Europe. It claims over 25% return […]

June 7, 2016 - 2 minutesmins - By Dani Bancroft

cevec virus gene therapy paragon manufacture

News and Trends 7 Jun 2016

German Biotech partners up in the US for scalable viral vector production in Gene Therapy

Cevec is joining forces with US-based Paragon. The objective is to make Cevec’s scalable CAP expression technology the industry standard for glycoproteins and viral vectors in gene therapies. Based in Cologne (Germany), Cevec tackles with its human cell-based expression systems (CAP-GT and CAP-Go) two big challenges in Biotech manufacturing – industrial scale production of viral vectors […]

June 7, 2016 - 4 minutesmins - By Denise Neves Gameiro

zurich biotech octapharma ehtz switzerland

News and Trends 7 Jun 2016

Zurich is not all about Money – here are 9 Biotechs proving it!

The biggest city in Switzerland, Zurich, is one of Europe’s top financial centers and home to the SIX Swiss Exchange (SWX). It’s also one of the most expensive cities in Europe to live in (as my Swiss colleague Claire could confirm). With so much money nearby, how does the local Biotech ecosystem looks like? The biggest Biotech/mid-size Pharma in […]

June 7, 2016 - 5 minutesmins - By Denise Neves Gameiro

XenoTech sekisui ketonozole biotech cro clinical trials transporters drug pharmacokinetcis

News and Trends 7 Jun 2016

Understand which transporters are involved in a drug’s absorption, distribution & excretion

How can you build the best case for a new drug application to the regulatory agencies? Preclinical studies are a crucial part in determining the pharmacokinetics of a drug – and more specifically how it is going to interact with drug transporters. So reaching out to the leading provider and consultant in this area (with strong […]

June 7, 2016 - 4 minutesmins - By Dani Bancroft

vedanta microbiome seventure health capital fund finance jj live biotech

News and Trends 6 Jun 2016

‘Living’ Therapeutics in Boston attract major French Microbiome Money

Health for Life Capital, managed by Seventure Partners, has invested $8M (€7.15M) as part of a $50M financing round completed by Boston-based Vedanta Biosciences. This seems to be a great match between one of the most influential Microbiome investors and one of the most successful Microbiome biotechs. The basis for the financing is a live-bioproduct from […]

June 6, 2016 - 3 minutesmins - By Dani Bancroft

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

CRISPR Thx in yet another Collaboration, this time for Muscle Dystrophy

Genticel is vaccinating against Cervical Cancer AFTER Infection

How was it inside the ‘World Most Important Cancer Meeting’ of the Year?

German Biotech launches Phase II in a hot Target for Inflammation

Brain Cell Transplant could help with incurable Neurodegenerative Disease

Biotech, France and L’Oréal Team up for World First Biofuel Plant using Beets

12 European Biotechs which ‘stole the show’ at World most Important Cancer Meeting

New Massive €250M Investment Fund Closed for European Biotech

German Biotech partners up in the US for scalable viral vector production in Gene Therapy

Zurich is not all about Money – here are 9 Biotechs proving it!

Understand which transporters are involved in a drug’s absorption, distribution & excretion

‘Living’ Therapeutics in Boston attract major French Microbiome Money

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!